We are live on ! Find out more
IRD

Opus Genetics
IRD

35 hedge funds and large institutions have $12.9M invested in Opus Genetics in 2014 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

485% more capital invested

Capital invested by funds: $2.21M → $12.9M (+$10.7M)

94% more funds holding

Funds holding: 18 → 35 (+17)

Holders
35
Holders Change
+17
Holders Change %
+94.44%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
12
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$2.39M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.78M
3
SFM
Sphera Funds Management
Israel
+$571K
4
AQR Capital Management
AQR Capital Management
Connecticut
+$429K
5
U
UBS
Switzerland
+$375K

Top Sellers

Rank Fund Capital Flow
1
Nomura Holdings
Nomura Holdings
Japan
-$55K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$2K
3
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.84M +$1.78M +3,283 +80%
Millennium Management
2
Millennium Management
New York
$2.29M +$2.39M +4,412 New
SFM
3
Sphera Funds Management
Israel
$2.17M +$571K +1,055 +34%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$548K +$260K +480 +83%
AQR Capital Management
5
AQR Capital Management
Connecticut
$411K +$429K +793 New
Morgan Stanley
6
Morgan Stanley
New York
$389K +$370K +684 +1,021%
U
7
UBS
Switzerland
$381K +$375K +694 +1,779%
PAM
8
Panagora Asset Management
Massachusetts
$354K +$369K +683 New
BG
9
BlackRock Group
United Kingdom
$340K +$355K +657 New
VKH
10
Virtu KCG Holdings
New York
$331K +$344K +637 New
CS
11
Credit Suisse
Switzerland
$227K +$237K +439 New
Northern Trust
12
Northern Trust
Illinois
$215K +$120K +222 +115%
BCM
13
Bridgeway Capital Management
Texas
$194K +$203K +375 New
NFC
14
Northeast Financial Consultants
Connecticut
$162K +$169K +313 New
Wells Fargo
15
Wells Fargo
California
$157K +$164K +303 New
Commonwealth Equity Services
16
Commonwealth Equity Services
Massachusetts
$99K +$66.5K +123 +178%
Goldman Sachs
17
Goldman Sachs
New York
$98K +$56.8K +105 +125%
BMC
18
Benin Management Corp
Connecticut
$90K – – –
JP Morgan Chase
19
JP Morgan Chase
New York
$88K +$91.4K +169 New
OC
20
Oppenheimer & Co
New York
$86K +$90.3K +167 New
GC
21
Guggenheim Capital
Illinois
$79K +$35.2K +65 +75%
Bank of America
22
Bank of America
North Carolina
$70K +$16.2K +30 +29%
RCM
23
Rotella Capital Management
Washington
$46K +$48.1K +89 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$45K +$46.5K +86 New
State Street
25
State Street
Massachusetts
$39K – – –
1
2

IRD Hedge Fund Activity: Q1 2014 in Review

35 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q1 2014, worth a combined $12.9M — up 485% from $2.21M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new IRD positions and 3 closed out — a net gain of 17 holders — while 12 added to existing stakes and 0 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $2.39M. The largest seller was Nomura Holdings, exiting entirely with an estimated $55K sold.

  • 35 institutional investors held Opus Genetics (IRD) as of Q1 2014, up from 18 in Q4 2013.
  • Funds reported $12.9M of Opus Genetics stock for Q1 2014, up 485% quarter-over-quarter.
  • 20 funds opened new Opus Genetics positions in Q1 2014 and 3 closed out, a net change of +17 holders.
  • The largest Opus Genetics buyer in Q1 2014 was Millennium Management, an estimated $2.39M added.
  • The largest Opus Genetics seller in Q1 2014 was Nomura Holdings, an estimated $55K sold.

Based on aggregated 13F filings for Q1 2014.